SVB, MidCap Financial Provide $100MM Facility to Organogenesis

SVB and MidCap Financial entered a $100 million credit agreement with Organogenesis, a regenerative medicine company focused on product solutions for the advanced wound care and surgical and sports medicine markets.

SVB Provides Organogenesis with $25MM Credit Facility

Regenerative medicine company Organogenesis entered into a $25 million revolving line of credit agreement with Silicon Valley Bank.